Treatment of Peyronie's disease with oral pentoxifylline

Nature Clinical Practice Urology

Volumn 3, Issue 2, 2006, Pages 111-115

  Brant, William O ^a   Dean, Robert C ^b   Lue, Tom F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Pentoxifylline; Peyronie's disease; Ultrasound

Indexed keywords

ALPHA TOCOPHEROL; PENTOXIFYLLINE; SILDENAFIL;

ADULT; ARTICLE; CALCIFICATION; CASE REPORT; CAUCASIAN; CORPUS CAVERNOSUM; ECHOGRAPHY; HUMAN; MALE; PENIS ERECTION; PEYRONIE DISEASE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEXUAL INTERCOURSE;

ADMINISTRATION, ORAL; HUMANS; MALE; MIDDLE AGED; PENILE INDURATION; PENTOXIFYLLINE; VASODILATOR AGENTS;

EID: 32644441928     PISSN: 17434270     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpuro0409     Document Type: Article

References (19)

1. Schwarzer U et al. (2001) The prevalence of Peyronie's disease: Results of a large survey. BJU Int 88: 727-730
2. Mulhall JP et al. (2004) Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening. J Urol 171: 2350-2353
3. Gholami SS et al. (2002) Peyronie's disease: A review. J Urol 169: 1234-1241
4. Williams JL and Thomas GG (1970) The natural history of Peyronie's disease. J Urol 103: 75-76
5. Gelbard MK et al. (1990) The natural history of Peyronie's disease. J Urol 144: 1376-1379
6. Zargooshi J (2004) Trauma as the cause of Peyronie's disease: Penile fracture as a model of trauma. J Urol 172: 186-188
7. Levine LA and Greenfield JM (2003) Establishing a standardized evaluation of the man with Peyronie's disease. Int J Impot Res 15 (Suppl): S103-S112
8. Hauck EW et al. (2003) Diagnostic value of magnetic resonance imaging in Peyronie's disease: A comparison both with palpation and ultrasound in the evaluation of plaque formation. Eur Urol 43: 293-300
9. Chiao TB and Lee AJ (2005) Role of pentoxifylline and vitamin E in attenuation of radiation-induced fibrosis. Ann Pharmacother 39: 516-522
10. Delanian S et al. (2005) Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis. J Clin Oncol 22: 1-10
11. Haddad P et al. (2005) Pentoxifylline and vitamin E combination for superficial radiation-induced fibrosis: A phase II clinical trial. Radiother Oncol 77: 324-326
12. Hille A et al. (2005) Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis. Strahlenther Onkol 181: 606-614
13. Adams LA et al. (2004) A pilot trial of pentoxifylline in nonalcoholic steatohepatitis. Am J Gastroenterol 99: 2365-2368
14. Georges C et al. (2004) Case report: Resolution of symptomatic epidural fibrosis following treatment with combined pentoxifylline-tocopherol. Br J Radiol 77: 885-887
15. Delanian S and Lefaix JL (2002) Complete healing of severe osteoradionecrosis with treatment combining pentoxifylline, tocopherol and clodronate. Br J Radiol 75: 467-469
16. Valente EG et al. (2003) L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures. Nitric Oxide 9: 229-244
17. Videla S et al: Selective inhibition of phosphodiesterase-4 ameliorates chronic colitis and prevents intestinal fibrosis. J Pharmacol Exp Ther, in press
18. Gumus B et al. (2004) Histopathological effects of sildenafil citrate on rat corpus cavernosum. Acta Histochem 106: 37-45
19. Schwartz EJ et al. (2004) Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol 171: 771-774